Erlotinib Tablet 150mg is a critical, precision-engineered oncology medication specifically developed to target cancers with epidermal growth factor receptor (EGFR) mutations. As a...

Erlotinib Tablet 150mg is a critical, precision-engineered oncology medication specifically developed to target cancers with epidermal growth factor receptor (EGFR) mutations. As a tyrosine kinase inhibitor, it works by blocking the abnormal signaling within cancer cells that drives their uncontrolled growth and division. Each tablet is manufactured to deliver a precise 150mg dose of the active pharmaceutical ingredient under rigorous Good Manufacturing Practice (GMP) standards, ensuring batch-to-batch consistency and therapeutic reliability. This product is supplied through trusted channels to meet the bulk procurement needs of pharmaceutical distributors, hospital networks, and healthcare institutions dedicated to advanced cancer care.

This medication is integral to treatment protocols in hospital oncology wards, comprehensive cancer centers, and specialized clinics worldwide. It is used specifically for managing non-small cell lung cancer (NSCLC) and pancreatic cancer in patients whose tumors test positive for relevant EGFR mutations. Pharmaceutical distributors and wholesalers facilitate its availability, supplying it directly to hospital formularies and pharmacy departments that serve patients undergoing targeted therapy. Its use represents a shift towards personalized medicine, where treatment decisions are guided by the genetic profile of a patient's tumor, allowing for more effective and tailored care.

Partnering with a reliable supplier ensures uninterrupted access to this essential medication, which is vital for maintaining continuous patient treatment schedules. We guarantee a robust and transparent supply chain, coupled with stringent quality control from manufacturing through to delivery. Our commitment to competitive pricing helps distributors and healthcare providers manage treatment costs effectively without compromising on quality. We provide complete supporting documentation, including certificates of analysis and regulatory compliance paperwork, to facilitate smooth procurement and integration into institutional systems.

Key Features:
- Precise 150mg dosage formulation ensuring consistent and accurate therapeutic delivery.
- Manufactured in compliance with strict international GMP and quality assurance standards.
- Specifically designed to target and inhibit the EGFR tyrosine kinase pathway in mutated cancer cells.
- Extended shelf life supported by validated stability data and maintained through controlled supply chain logistics.
- Accompanied by comprehensive batch documentation, including certificates of analysis and traceability records.

Benefits:
- Provides a reliable, targeted treatment option for patients with specific EGFR-mutated cancers.
- Ensures consistent therapeutic outcomes through high-quality, standardized manufacturing processes.
- Supports healthcare institutions in implementing modern, precision medicine treatment protocols.
- Offers supply chain reliability and consistent availability for critical oncology medications.
- Delivers value through competitive pricing and complete regulatory documentation for easy procurement.